Pharmacology & Therapeutics

Papers
(The H4-Index of Pharmacology & Therapeutics is 57. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Characteristics of anticancer activity of CBP/p300 inhibitors – Features of their classes, intracellular targets and future perspectives of their application in cancer treatment939
SIRT3: A potential therapeutic target for liver fibrosis340
Editorial Board312
Epigenetic determinants and non-myocardial signaling pathways contributing to heart growth and regeneration232
Berberine prevents NAFLD and HCC by modulating metabolic disorders207
Is depression the missing link between inflammatory mediators and cancer?197
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?194
TAS-102: A resurrected novel Fluoropyrimidine with expanding role in the treatment of gastrointestinal malignancies162
Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases?160
Novel pharmacological strategies to treat cognitive dysfunction in chronic obstructive pulmonary disease157
Unraveling diverse roles of noncoding RNAs in various human papillomavirus negative cancers136
Immune-related adverse events of cancer immunotherapies targeting kinases133
Measuring brain docosahexaenoic acid turnover as a marker of metabolic consumption126
The role of lidocaine in cancer progression and patient survival117
Inter and intra-tumoral heterogeneity as a platform for personalized therapies in medulloblastoma115
Anticancer drug delivery by focused ultrasound-mediated blood-brain/tumor barrier disruption for glioma therapy: From benchside to bedside114
Prognostic and predictive molecular biomarkers in advanced colorectal cancer113
Bioactive lipid regulation of platelet function, hemostasis, and thrombosis112
Pharmacological interventions for intraplaque neovascularization in atherosclerosis104
Mechanisms of skeletal muscle-tendon development and regeneration/healing as potential therapeutic targets97
Opportunities and challenges in the therapeutic exploitation of histamine and histamine receptor pharmacology in inflammation-driven disorders95
A novel rationale for targeting FXI: Insights from the hemostatic microRNA targetome for emerging anticoagulant strategies93
Impact of drug treatment and drug interactions in post-stroke epilepsy93
CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control93
Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer88
Organ-on-a-chip platforms as novel advancements for studying heterogeneity, metastasis, and drug efficacy in breast cancer86
Adenosine receptor signalling as a driver of pulmonary fibrosis85
Signaling pathways driving ocular malignancies and their targeting by bioactive phytochemicals84
Editorial Board83
Targeting the dysfunction of glutamate receptors for the development of novel antidepressants81
Exploiting the obesity-associated immune microenvironment for cancer therapeutics81
The role of the STAT3 signaling transduction pathways in radioresistance79
Targeting adipokines in polycystic ovary syndrome and related metabolic disorders: from experimental insights to clinical studies79
Transcription factors in epithelial ovarian cancer: histotype-specific drivers and novel therapeutic targets78
Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy78
Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies77
Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular disease76
Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain73
Disease progression modeling with temporal realignment: An emerging approach to deepen knowledge on chronic diseases73
The unique function of p130Cas in regulating the bone metabolism72
Chemical inhibitors targeting histone methylation readers71
Current investigations on clinical pharmacology and therapeutics of Glucose-6-phosphate dehydrogenase deficiency71
Inflammation, lipids, and pain in vulvar disease69
Editorial Board68
Editorial Board68
Editorial Board67
Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies65
Retracing our steps: A review on autism research in children, its limitation and impending pharmacological interventions65
Behavioral characterization, potential clinical relevance and mechanisms of latent pain sensitization63
Indirect mediators of systemic health outcomes following nanoparticle inhalation exposure62
Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease62
Hedgehog pathway and its inhibitors in chronic obstructive pulmonary disease (COPD)61
Editorial Board59
Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis58
Tubulin modifying enzymes as target for the treatment of tau-related diseases58
The multifaceted functions of RNA helicases in the adaptive cellular response to hypoxia: From mechanisms to therapeutics57
Naturally occurring mutations in G protein-coupled receptors associated with obesity and type 2 diabetes mellitus57
Novel treatments for autism spectrum disorder based on genomics and systems biology57
Resolving inflammation by TAM receptor activation57
0.043587923049927